|
Shield AI, an aerospace and defense technology provider, raised $2 billion in new funding, giving the company a $12.7 billion post-money valuation. The financing includes a $1.5 billion Series G round from Advent International, the strategic investment group of JPMorganChase's Security and Resiliency Initiative, Snowpoint Ventures, Innovation X Advisors, Riot Ventures, Disruptive, Apandion and others. Shield AI will use a portion of the funding to acquire defense software company Aechelon.
Harvey, a San Francisco-based startup providing an AI operating system for legal work, scored $200 million in new funding, valuing the company at $11 billion. GIC and Sequoia Capital co-led the round, which included participation from Andreessen Horowitz, Kleiner Perkins, Conviction Partners and others.
Xona, a Burlingame, Calif.-based satellite navigation technology startup, landed $170 million in Series C funding. Mohari Ventures Natural Capital led the investment, which included additional support from Craft Ventures, Iconiq, Woven Capital and others.
Cents, a New York-based business management platform for laundromats and dry cleaners, closed a $140 million Series C round. Sumeru Equity Partners led the investment, with Managing Partner Sanjeet Mitra joining the company’s board. Camber Creek also participated in the round.
Granola, a London-based meeting notes app, secured $125 million in Series C financing at a $1.5 billion valuation. Danny Rimer at Index Ventures led the round, which saw participation from Mamoon Hamid at Kleiner Perkins, in addition to Lightspeed Venture Partners, Spark Capital and NFDG.
Dash0, an agentic observability platform, nabbed $110 million in Series B funding, valuing the company at $1 billion. Balderton Capital led the round, with Rana Yared joining the board.
NoTraffic, an Overland Park, Kansas-based AI-powered mobility platform for traffic management, snagged $90 million in Series C funding led by PSG Equity.
Pinnacle Medicines, a startup developing new oral peptide therapeutics, completed an $89 million Series B round. LAV and Foresite Capital led the investment, which included contributions from Quan Capital, Hankang Capital, OrbiMed and others. Pinnacle has offices in Shanghai and Doylestown, Pa.
Gilgamesh Pharma, a New York-based startup developing breakthrough therapies for psychiatric and neurological disorders, closed a $60 million Series A round. Satori Neuro led the funding, which saw participation from investors including Prime Movers Lab.
Normal Computing, a New York-headquartered startup building AI software for semiconductor design and thermodynamic computing chips, grabbed $50 million in strategic funding led by Samsung Catalyst Fund.
Terrestrial Bio, a Boston-based biotech company developing a skin patch and applicator for administering therapies, raised $50 million in Series C funding. RA Capital Management led the round, which included support from Engine Ventures and others. The company was formerly known as Vaxess Technologies.
Origin, a U.K.-based employee benefits platform, obtained $30 million in Series A+ funding led by Notion Capital.
|